[1]
T. D. Nguyen et al., “PREVALENCE OF NON-ALBUMINURIC CKD, ASSOCIATED FACTORS, AND TREATMENT OUTCOMES WITH DAPAGLIFLOZIN COMBINATION THERAPY IN TYPE 2 DIABETES MELLITUS PATIENTS WITH CHRONIC KIDNEY DISEASE AT CAN THO UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL”, CTJUMP, no. 85, pp. 36–42, Mar. 2025.